Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PNC +3.5%, MTB +1.1%
Other news:
- IBRX +25.3% (enrollment in its registrational trial in BCG-naïve non-muscle-invasive bladder cancer has exceeded internal expectations; Anticipates submitting a BLA to FDA by end of 2026)
- ASTS +7.4% (wins prime IDIQ position on Missile Defense Agency SHIELD program)
- MU +5.5% (Director Teyin Liu bought 23,200 shares at $335.97 - $337.77 worth more than $7.8 mln)
- NVO +4.4% (UK Medicines regulator approves up to 7.2mg dose of semaglutide ?(Wegovy) for patients with obesity only)
- WWD +3.6% (to wind down China on-highway natural gas truck business)
- COHR +3.6% (launches FieldMax Touch and FieldMax Touch Pro)
- CC +2.4% ( to sell the remaining land at its former titanium dioxide manufacturing location in Taiwan)
- BBIO +2% (prices offering of $550 mln of 0.75% convertible senior notes due 2033)
- SLVM +1.4% (CEO letter to shareholders)
- UMAC +1.3% ($2.1 mln order for drone components)
- LWLG +1.3% (MOU with QPICs to accelerate the use of electro-optic polymers)
- WS +1.3% (to acquire Kloeckner & Co)
- GVA +1.2% (selected for $157 mln project by the City of Tucson)